全文获取类型
收费全文 | 63530篇 |
免费 | 5448篇 |
国内免费 | 3287篇 |
专业分类
耳鼻咽喉 | 599篇 |
儿科学 | 814篇 |
妇产科学 | 907篇 |
基础医学 | 8117篇 |
口腔科学 | 1218篇 |
临床医学 | 7988篇 |
内科学 | 10074篇 |
皮肤病学 | 880篇 |
神经病学 | 3721篇 |
特种医学 | 2662篇 |
外国民族医学 | 37篇 |
外科学 | 6929篇 |
综合类 | 7814篇 |
现状与发展 | 7篇 |
一般理论 | 18篇 |
预防医学 | 4559篇 |
眼科学 | 1671篇 |
药学 | 6110篇 |
44篇 | |
中国医学 | 2689篇 |
肿瘤学 | 5407篇 |
出版年
2024年 | 170篇 |
2023年 | 898篇 |
2022年 | 2288篇 |
2021年 | 3119篇 |
2020年 | 2127篇 |
2019年 | 2049篇 |
2018年 | 2208篇 |
2017年 | 1872篇 |
2016年 | 2043篇 |
2015年 | 2834篇 |
2014年 | 3518篇 |
2013年 | 3354篇 |
2012年 | 5275篇 |
2011年 | 5445篇 |
2010年 | 3360篇 |
2009年 | 2748篇 |
2008年 | 3730篇 |
2007年 | 3586篇 |
2006年 | 3366篇 |
2005年 | 3069篇 |
2004年 | 2227篇 |
2003年 | 2109篇 |
2002年 | 1842篇 |
2001年 | 1271篇 |
2000年 | 1268篇 |
1999年 | 1221篇 |
1998年 | 709篇 |
1997年 | 730篇 |
1996年 | 587篇 |
1995年 | 486篇 |
1994年 | 408篇 |
1993年 | 286篇 |
1992年 | 371篇 |
1991年 | 265篇 |
1990年 | 245篇 |
1989年 | 208篇 |
1988年 | 163篇 |
1987年 | 148篇 |
1986年 | 123篇 |
1985年 | 95篇 |
1984年 | 60篇 |
1983年 | 66篇 |
1982年 | 36篇 |
1981年 | 37篇 |
1980年 | 22篇 |
1979年 | 38篇 |
1978年 | 19篇 |
1974年 | 23篇 |
1973年 | 19篇 |
1969年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Georgia Robins Sadler Paula R. Beerman Kathy Lee Jenny Hung Helene Nguyen Janet Cho Wennie Huang 《Journal of cancer education》2012,27(4):612-617
Asian American women's historically low breast cancer mortality rate has remained constant as rates decreased for all other races. From 2000 to 2004, a randomized controlled trial explored the Asian grocery store-based breast cancer education program's impact on Chinese, Filipino, Korean, and Vietnamese women (n?=?1,540). Women aged 40 and older and non-adherent for annual screening mammograms were more likely to schedule a mammogram after receiving the breast cancer education program than women randomized to the prostate cancer program (X 2?=?3.85, p?=?0.05). With the right program ingredients, late adopters of breast cancer screening can be prompted to change. 相似文献
992.
993.
994.
Shu-Lian Wang Ye-Xiong Li Yong-Wen Song Wei-Hu Wang Jing Jin Yue-Ping Liu Xin-Fan Liu Zi-Hao Yu 《Practical radiation oncology》2012,2(2):106-113
PurposeThis study aimed to evaluate the outcome of patients who had received postmastectomy chest wall radiotherapy using a single electron beam, and to identify the relevant factors that influenced prognosis.MethodsThe medical records of patients with breast cancer treated with postmastectomy radiotherapy from January 2000 to December 2004 were retrospectively analyzed (n = 328). Two hundred seventy-one (82.6%) patients were staged as (tumor-nodes-metastasis [TNM]) T3-4, any N, M0; or T1-2, N2-3, M0, and 57 (17.4%) patients were staged as T1-2, N1, M0. All patients received chest wall radiation with a 6-10 MeV electron beam. In addition, 327 patients (99.7%) received supraclavicular node radiation, 67 (20.4%) axillary radiation, and 35 (10.7%) internal mammary chain (IMC) radiation. Chemotherapy with anthracycline and taxane was given to 323 patients (98.5%). Of patients with positive hormone receptor, 183 (82.8%) received hormone therapy and 8 patients with negative and 3 patients with unknown hormone receptor received hormone therapy. Locoregional recurrence (LRR), distant metastasis (DM), and overall survival (OS) were calculated using the Kaplan-Meier method, and the differences assessed by log-rank test.ResultsThe median follow-up time was 78 months (range, 5-123 months) for patients who remained alive. The 5-year LRR, DM, disease-free survival and OS rates were 5.9%, 26.2%, 72.5%, and 83.1%, respectively. LRR occurred in 1 or more sites in 21 patients. The 5-year recurrence rates in the chest wall, supraclavicular node, axilla, and internal mammary chain were 1.9%, 2.3%, 2.9%, and 0%, respectively. In multivariate analysis, hormone therapy was the only independent favorable prognostic factor for LRR (P = .017). LRR was significantly associated with DM and OS. The 5-year DM rate was 82.9% and 22.7% (P < .0001) and the 5-year OS rate was 52.8% and 84.7% (P < .0001) for patients with or without LRR. The treatment-related toxicity was low, with the incidence of symptomatic pneumonitis being 0.3%.ConclusionsBreast cancer patients can be treated with postmastectomy single electron beam radiotherapy with excellent local control and low toxicity. 相似文献
995.
Ovarian cancer is an important health concern worldwide. The majority of patients present with advanced disease, and despite initial chemosensitivity, most relapse and die from their disease. Better therapeutic options are urgently required. Maximal surgical debulking in combination with platinum/taxane chemotherapy has been the standard of care in advanced ovarian cancer since the mid-1990s. Trials investigating the addition of a third chemotherapeutic agent have disappointingly failed to demonstrate benefit. Intra-peritoneal therapy demonstrated improvements in outcomes in some trials, but at the cost of increased toxicity and inconvenience. Encouragingly, prospective data has now demonstrated benefits with bevacizumab in both the first-line and relapsed settings; however, interpretation is complex, particularly considering recent data demonstrating non-inferiority of neo-adjuvant chemotherapy with delayed primary surgery, and other data demonstrating a substantial improvement in outcome as a result of first-line paclitaxel dose fractionation. This article reviews the recent advances in ovarian cancer treatment and discusses current management and key areas for future research. 相似文献
996.
目的:观察重组人血管内皮抑制素(恩度)联合单药治疗老年晚期非小细胞肺癌( NSCLC)的疗效和安全性.方法:2007-10-01-2011-06-30,本院63例经病理确诊符合入选标准的老年晚期NSCLC患者,通过简单随机抽样的方法,按1∶1随机分成治疗组和对照组,治疗组接受恩度联合吉西他滨(GEM)治疗方案,对照组只用吉西他滨方案.化疗2个周期后按照实体瘤疗效评价标准(RECIST)评价客观有效率(ORR)、疾病控制率(DCR)、中位至疾病进展时间(mT-TP).每周期按照NCI CTC 3.0版标准评价毒性反应(AE).结果:所有的病例均进行疗效和安全评价,治疗组部分有效(PR)6例,疾病稳定(SD)19例,疾病进展(PD)6例.ORR与对照组比较,差异无统计学意义(19.4% vs 12.5%, P=0.457).两组DCR差异具有统计学意义(80.7% vs 56.3%,P=0.038).两组mTTP对比,差异有统计学意义(3.9个月vs 3.4个月,P=0.024).治疗组和对照组分别已死亡的18例和20例,中位生存时间(median overall survival,mOS)差异无统计学意义(9.2个月vs 7.5个月,P=0.524).毒性反应以骨髓抑制发生率较高,多为G1/G2,G3/G4 少见,两组差异无统计学意义.结论:恩度联合单药化疗老年NSCLC显示出一定的抗肿瘤活性和较好的疾病控制率,安全性较好,临床受益率高,是一种有临床应用前景的治疗方法. 相似文献
997.
998.
We report the design and synthesis of novel FTPA-triazole compounds as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), through a focus on thioether and isoprenoid mimetics. These mimetics were coupled utilizing a copper-assisted cycloaddition to assemble the potential inhibitors. Using the resulting triazole from the coupling as an isoprenyl mimetic resulted in the biphenyl substituted FTPA triazole 10n. This lipid-modified analog is a potent inhibitor of Icmt (IC(50) = 0.8 ± 0.1 μM; calculated K(i) = 0.4 μM). 相似文献
999.
目的探讨胆石利通联合肝切除治疗肝内外胆管结石的疗效。方法 2006年6月~2011年6月,笔者所在医院共收治肝内外复杂胆管结石病242例,其中162例行肝叶或肝段切除术。162例行肝叶或肝段切除术患者根据是否使用胆石利通片随机分为联合组(胆石利通联合肝切除)和对照组(消炎利胆片联合肝切除)各81例,比较两组的疗效及并发症情况。结果两组患者的年龄、性别、病史、病程等基础资料比较,差异无统计学意义(P>0.05)。联合组的总有效率93.8%,明显高于对照组(76.5%),差异有统计学意义(P<0.05)。联合组的并发症例数明显少于对照组,差异有统计学意义(P<0.05)。结论胆石利通联合肝切除技术治疗肝内外胆管结石,可以明确提高临床疗效,降低并发症的发生率,值得推广。 相似文献
1000.
目的探讨非小细胞肺癌(NSCLC)组织中金属硫蛋白(metallothionein,MT)的表达及临床意义。方法采用免疫组织化学SP法检测68例NSCLC和25例肺良性疾病中MT的表达,分析其与NSCLC临床病理特征、预后以及耐药蛋白GST-π和TopoⅡ表达的关系。结果MT在NSCLC组织中表达显著高于肺良性病变组织(P<0.05),与年龄、分化程度有关;MT表达患者术后生存期明显短于不表达者。MT表达和GST-π、TopoⅡ表达无相关性(P>0.05)。结论MT在NSCLC组织中存在不同程度的高表达,且与某些生物学行为有关,可以作为评价预后的指标。 相似文献